Compare AMRX & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | BBWI |
|---|---|---|
| Founded | 2002 | 1963 |
| Country | United States | United States |
| Employees | N/A | 60735 |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2018 | 1994 |
| Metric | AMRX | BBWI |
|---|---|---|
| Price | $13.41 | $18.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 15 |
| Target Price | $15.60 | ★ $24.88 |
| AVG Volume (30 Days) | 1.4M | ★ 5.5M |
| Earning Date | 05-01-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 4.36% |
| EPS Growth | ★ 157.89 | N/A |
| EPS | 0.22 | ★ 3.11 |
| Revenue | N/A | ★ $7,291,000,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.13 | $2.19 |
| P/E Ratio | $59.44 | ★ $6.01 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.02 | $14.28 |
| 52 Week High | $15.42 | $34.29 |
| Indicator | AMRX | BBWI |
|---|---|---|
| Relative Strength Index (RSI) | 60.20 | 43.94 |
| Support Level | $12.45 | $17.01 |
| Resistance Level | $13.54 | $19.89 |
| Average True Range (ATR) | 0.51 | 1.05 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 69.21 | 17.81 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,900 retail stores), similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.